Navigation Links
Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer
Date:8/8/2008

EAST SETAUKET, N.Y., Aug. 8 /PRNewswire-FirstCall/ -- Lixte Biotechnology Holdings, Inc. (OTC Bulletin Board: LIXT) announced today that lead compounds from each of two different types of drugs being developed as potential treatment for specific types of brain cancers have activity against human pancreatic cancers in a mouse model.

Dr. John S. Kovach, President and CEO of Lixte, said, "Lixte previously reported that lead compounds from each of two different classes of pharmacologic agents have significant inhibitory activity against several types of human cancers in the test tube and against brain cancers in animal models. We have now found that two different lead compounds also have statistically significant activity against human pancreatic cancer cells growing in mice. These are early studies and there is no evidence that these drugs are able to eliminate pancreatic cancers but rather slow their growth. We are encouraged, however, that two classes of our drugs have activity against this devastating cancer in addition to glioblastoma multiforme, the most common and most malignant form of brain cancer."

About Lixte Biotechnology Holdings, Inc.:

Lixte Biotechnology Holdings, Inc. is a cancer therapeutics and diagnostics company. Founded as a biomarker-diagnostics company in 2005, Lixte develops new chemotherapy drugs targeting molecular abnormalities of common human cancers.

Forward-Looking Statements:

This announcement contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. For example, statements regarding the Company's financial position, business strategy and other plans and objectives for future operations, and assumptions and predictions about future product demand, supply, manufacturing, costs, marketing and pricing factors are all forward-looking statements. These statements are generally accompanied by words
'/>"/>

SOURCE Lixte Biotechnology Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research
2. Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement
3. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
4. Dr. Ari Kiev to be Featured Speaker at Biotechnology Conference Wall Street Unplugged: The Trout Group Investor Seminar in New York July 30
5. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells
6. Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug Candidate
7. Genetic Engineering & Biotechnology News Reports on the Growing Role of Ion-Channel Studies in Global Biotech R&D
8. Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
9. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
10. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
11. Innocoll Announces Dosing of Last Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-Operative Pain

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...f.,Nov.25/PRNewswire/-- ChemoCentryx,Inc.,announc...PROTECT-1(theProspectiveRandomizedOralTherapyEvalu...2-B)inpatientswithmoderate-to-severeCrohn,sdisease...dtolerabilityprofile.Thestudydemonstratedevidenceo...definedasa70-pointdecreaseintheCrohn,sDiseaseActiv...
(Date:11/24/2009)....24/PRNewswire-FirstCall/--Endologix,Inc.(Nasdaq: ...rticdisorders,announcedtodaythatithasfiledamotiont...ngementlawsuitbroughtagainstitinOctober2009byCook,...tinIndianapolis,Indiana. ,, Endologixhasrequest...entandTrademarkOffice(USPTO)conductsproceedingstor...
(Date:11/24/2009)...RNewswire-FirstCall/--AnadysPharmaceuticals,Inc.(N...1stAnnualPiperJaffrayHealthcareConferenceonTuesday...renceisbeingheldatTheNewYorkPalaceHotel.SteveWorla...,willprovideanoverviewofAnadysanditsclinicaldevelo...resentationwillbesimultaneouslywebcastandcanbeacce...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Infant Head Flattening Linked to Ear Infections 58248 1Infant Head Flattening Linked to Ear Infections 58248 2QImaging Introduces 26quot 3BQTube 26quot 3B a Video based Learning Tool for Scientific 26amp 3B Industrial Digital Imaging 14249 1QImaging Introduces 26quot 3BQTube 26quot 3B a Video based Learning Tool for Scientific 26amp 3B Industrial Digital Imaging 14249 2New Cardiovascular Biomarker Available for Scientist in North America 5054 1New Cardiovascular Biomarker Available for Scientist in North America 5054 2
...als (SPI) has filed,an Investigational New Drug Ap... a proprietary formulation of ebselen for the prev...toxicity. The oral capsule,containing ebselen, SPI...r,and head and neck cancer patients receiving plat...elopment program for SPI to enter clinical testing...
...ody Have Greater Concentrations of,Stem Cells, AR...he lower abdomen and inner thigh through liposucti...ls, with higher stem cell concentrations,than othe...dy in August,s,Plastic and Reconstructive Surgery(...ociety of Plastic Surgeons (ASPS). This is the fir...
Other Medicine Technology:Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer 2Want a Reason to Love Your Lower Belly Fat? It's Rich in Stem Cells 2
(Date:11/25/2009)...wire/--IntroducingPariBeautyProfessionalArtistry,a...rededicatedtoprovidingprestigeformulasatirresistib...reandcolorcosmeticbrandtolaunchunderMakeupArtistry...anciscoandToronto,wasfoundedandismanagedbyaseasone...experienceintheindustry.PariBeautywillhaveasignifi...
(Date:11/25/2009)...g Today through Sunday, November 29th, PlushBeds.c... latex sofa bed mattress + an additional 10% site-...money back guarantee. Use the code “BLACKFRI...of this special offer. , ... will travel from Thanksgiving through the New Yea...
(Date:11/25/2009)... Consulting again commits to SAS70 Audit to demons... (PRWEB) November 25, 2009 -- Partners Con...enter operation has completed the American Institu...t on Auditing Standards (SAS) No. 70 type II audit...r validating the internal controls of service prov...
(Date:11/25/2009)... and guests, generosity will fund much-needed 2010...sboro, OR (PRWEB) November 25, 2009 -- In its 18th...n topped $607,700 in proceeds over the course of... the Big Board auction of special 2008 Pinot Noir ...2008 totals, over 400 guests bid enthusiastically ...
(Date:11/25/2009)...ackages.com, California,s designated Premier Partn...eness during the November 15 - December 31 Annual ...enroll in a zero-cost PPO Medicare Advantage plan.... available through BenefitPackages.com to eligible...labasas, CA (PRWEB) November 25, 2009 -- The state...
Breaking Medicine News(10 mins):Health News:Pari Beauty Professional Artistry 2Health News:Providing Comfort for Holiday Guests Just Got Easier 2Health News:Providing Comfort for Holiday Guests Just Got Easier 3Health News:Partners Consulting Completes SAS70 Audit 2Health News:Salud! The Oregon Pinot Noir Auction Raises Over $607,000 2Health News:Salud! The Oregon Pinot Noir Auction Raises Over $607,000 3Health News:BenefitPackages.com Reveals the Truth About No or Low Cost Medicare Supplement Plan Options Including Anthem Blue Cross Freedom Blue Regional PPO 2
...day that a short course of a drug could relieve se... //which kills half a million youngsters in mainly...ch is sold by the privately owned U.S. Company, Ro...e illness. Jean-Francois Rossignol of The Romark I...
...s is thought to have brought down the suicide rate... Public Library //of Science Medicine, nearly 30,0...I antidepressants, presently used to alleviate dep...inio of the University of Miami, who conducted the...
...s annual conference are planning to demand the gov...inks industry //. This is to mainly combat the nat... the sweeteners put in sugary drinks and also the ...ft drinks in U.S. schools are on the decline and a...
...rity Diabetes UK will be withdrawing diabetic food... advocated //the disuse of diabetic food which the...tional benefit. Squash drinks, chocolates, jam... products aren't required because diabetics should...
...ntists have claimed that they have identified thre...ied // on for many generations in families in Indi...sorders of Guru Nanak Dev University in collaborat...in the field of ophthalmology, to discover three g...
...today undergone treatment at the All India Institu... Sources close to him explained that Gogoi, ...y tour of Europe and Canada, was taken to AIIMS as... has been advised rest, and so he had postponed hi...
Other Medicine News:Health News:Indian Scientists Identify Cataract Causing Genes 2
Digital-Photo Adapter DC 01
Slit Lamp BM 900 with video
... a crescent-shaped interbody spacer used to provid...Xis is available in either titanium or PEEK-OPTIMA...lastic from Invibio. TraXis is implanted through a...ts spine and then curved across the midline to pro...
Universal Biomedical Amplifier (UBA-4204)
Medicine Products: